Patent Assignment
Reel/Frame 046294/0714
Assignment of Assignor's Interest
Recorded: 2018-06-05
Pages: 12
Assignor
INSTITUTE OF VIROLOGY OF THE SLOVAK ACADEMY OF SCIENCES
Executed: 2018-03-29
Assignee
BIOMEDICAL RESEARCH CENTRE OF THE SLOVAK ACADEMY OF SCIENCES
DÚBRAVSKA CESTA 9, BRATISLAVA, SLOVAKIA
Covered Properties
(53)
Mn Gene and Protein
Patent:
5,387,676 →
Application:
07/964,589 →
Mn-Specific Antibodies and Their Use in Cancer Treatment
Patent:
6,051,226 →
Application:
08/177,093 →
Mn Gene and Protein
Patent:
6,774,117 →
Application:
08/260,190 →
Methods of Imaging Neoplastic Disease and of Detecting and Quantifying Mn Protein/Polypeptide Using Mn-Specific Antibodies
Patent:
6,004,535 →
Application:
08/335,469 →
Mn Proteins, Polypeptides, Fusion Proteins and Fusion Polyptides
Patent:
5,972,353 →
Application:
08/477,504 →
Method of Inhibiting Tumor Growth Using Antibodies to Mn Protein
Patent:
5,955,075 →
Application:
08/481,658 →
Mn Gene and Protein
Patent:
6,204,370 →
Application:
08/485,049 →
Immunological Methods of Detecting Mn Proteins and Mn Polypeptides
Patent:
5,989,838 →
Application:
08/485,862 →
Detection and Quantitation of Mn Specific Antibodies
Patent:
6,093,548 →
Application:
08/485,863 →
Mn-Specific Antibodies and Hybridomas
Patent:
5,981,711 →
Application:
08/486,756 →
Mn Gene and Protein
Patent:
6,069,242 →
Application:
08/487,077 →
Mn Gene and Protein
Patent:
6,027,887 →
Application:
08/787,739 →
Mn Gene and Protein
Patent:
6,297,051 →
Application:
09/177,776 →
Mn Gene and Protein
Patent:
6,297,041 →
Application:
09/178,115 →
Mn Gene and Protein
Mn Gene and Protein
Patent:
7,713,704 →
Application:
09/807,949 →
Anti-Idiotype Antibodies to Mn Proteins and Mn Polypeptides
MN gene and protein
Application:
10/319,003 →
Mn/Ca Ix and Cancer Prognosis
MN gene and protein
Application:
10/795,933 →
Publication:
US 2004/0259126
Mn Gene and Protein
Soluble Form of Carbonic Anhydrase Ix (S-Ca Ix), Assays to Detect S-Ca Ix, Ca Ix's Coexpression with Her-2/Neu/C-Erbb-2, and Ca Ix-Specific Monoclonal Antibodies to Non-Immunodominant Epitopes
MN and hypoxia
Application:
11/166,997 →
Publication:
US 2006/0084123
Mn Gene and Protein
Anti-Anti-Idiotype Antibodies to Mn Proteins and Mn Polypeptides
Application:
11/448,576 →
Publication:
US 2006/0235203
Mn/Ca Ix/CA9 and Renal Cancer Prognosis
Mn Gene and Protein
Mn/Ca Ix and Egfr Pathway Inhibition
Mn Gene and Protein
MN Gene and Protein
Application:
11/929,415 →
Publication:
US 2008/0199881
MN Gene and Protein
Application:
11/929,474 →
Publication:
US 2008/0146780
Mn Gene and Protein
Mn Gene and Protein
MN Gene and Protein
Application:
11/932,697 →
Publication:
US 2008/0221309
Soluble Form of Carbonic Anhydrase IX (s-CA IX), Assays to Detect s-CA IX, CA IX's Coexpression with Her-2/neu/c-erbB-2, and CA IX-Specific Monoclonal Antibodies to Non-Immunodominant Epitopes
Application:
11/932,777 →
Publication:
US 2008/0177046
MN Gene and Protein
Application:
11/932,843 →
Publication:
US 2009/0118473
Mn Gene and Protein
Mn Gene and Protein
Soluble Form of Carbonic Anhydrase Ix (S-Ca Ix), Assays to Detect S-Ca Ix, Ca Ix's Coexpression with Her-2/Neu/C-Erbb-2, and Ca Ix-Specific Monoclonal Antibodies to Non-Immunodominant Epitopes
Soluble Form of Carbonic Anhydrase Ix (S-Ca Ix), Assays to Detect S-Ca Ix, Ca Ix's Coexpression with Her-2/Neu/C-Erbb-2, and Ca Ix-Specific Monoclonal Antibodies to Non-Immunodominant Epitopes
MN Gene and Protein
Application:
11/933,151 →
Publication:
US 2008/0176268
MN Gene and Protein
Application:
11/933,180 →
Publication:
US 2008/0214787
Image-Pickup Apparatus
Mn/Ca Ix and Breast Cancer Therapy
Mn/Ca Ix/CA9 and Renal Cancer Prognosis
Mn/Ca Ix and Cancer Prognosis
MN and Hypoxia
Application:
12/396,879 →
Publication:
US 2009/0239247
MN/CA9 Splice Variants
Application:
12/444,888 →
Publication:
US 2010/0056611
MN Gene and Protein
Application:
12/543,026 →
Publication:
US 2010/0080815
Mn/Ca Ix and Cancer Prognosis
MN Gene and Protein
Application:
12/850,432 →
Publication:
US 2010/0297752
MN/CA IX and EGFR Pathway Inhibition
Application:
12/900,282 →
Publication:
US 2011/0027225
Mn/Ca Ix and Egfr Pathway Inhibition
Application:
13/364,871 →
Publication:
US 2013/0209394
Related Assignments
(6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 31, 2005
From: PASTROEK, JAROMIR; PASTOREKOVA, SILVIA; ZATOVICOVA, MIRIAM; ZAVANDA, JAN
To: INSTITUTE OF VIROLOGY
Reel/Frame 016213/0483 →
Assignment of Assignor's Interest
Feb 12, 2009
From: EBERT, MATTHIAS; ROCKEN, CHRISTOPH
To: INST. OF VIROLOGY, SLOVAK ACADEMY OF SCIENCES
Reel/Frame 022269/0301 →
Assignment of Assignor's Interest
Feb 13, 2009
From: ZAVADA, JAN
To: INST. OF VIROLOGY, SLOVAK ACADEMY OF SCIENCES
Reel/Frame 022273/0562 →
Assignment of Assignor's Interest
Jul 27, 2009
From: BAYER PHARMACEUTICALS CORPORATION
To: BAYER HEALTHCARE LLC
Reel/Frame 023027/0804 →
Assignment of Assignor's Interest
Jan 11, 2010
From: PASTOREKOVA, SILVIA; PASTOREK, JAROMIR
To: INST. OF VIROLOGY, SLOVAK ACADEMY OF SCIENCES
Reel/Frame 023772/0016 →
Submission Is to Correct an Error Made in a Previously Recorded Document That Erroneously Affects the Identified Applications/Patents.
Jul 24, 2013
From: INSTITUTE OF VIROLOGY SLOVAK ACADEMY OF SCIENCES
To: INSTITUTE OF VIROLOGY SLOVAK ACADEMY OF SCIENCES
Reel/Frame 030871/0331 →